High sensitivity and specificity of nuclear HES1 in precancer, ISCC, and ADC strongly support its clinical significance for early detection, progression, and monitoring of patients with cervical dysplasia. This evidence concerns the gene HES1 and cervical intraepithelial neoplasia.